> "All things are hidden, obscure and debatable if the cause of the phenomena is unknown, but everything is clear if its cause be known."

-Louis Pasteur in The Germ Theory and Its Application to Medicine and Surgery

Introduction {#sec1-1}
============

*Gordonia* is a catalase-positive, aerobic, nocardioform, Gram positive staining actinomycete that also shows weak acid-fast staining.\[[@ref1]\] Several *Gordonia* species are commonly found in the soil.\[[@ref2]\] The bacterium has been isolated from the saliva of domesticated/wild dogs as well.\[[@ref3]\] In hospitalized patients, it is most commonly found in the setting of intravascular catheter-related infections. However, recent reports have shown that it has recently been isolated from sternal wounds,\[[@ref4]\] skin/neoplastic specimens, and from pleural effusions.\[[@ref5]\] *Gordonia* shares many common characteristics with *Rhodococcus* and *Nocardia*. Therefore, it is commonly misrecognized as *Nocardia* or *Rhodococcus*. Because *Gordonia* requires comprehensive morphological and biochemical testing, it is often difficult and cumbersome to isolate the species. It has an incubation period of a minimum of 4 days.\[[@ref6]\] Broad-range polymerase chain reaction (PCR) and sequencing, with genes like 16S rRNA or hsp65, are used to correctly identify the species.\[[@ref7]\] Here, we report a patient who presented with sternal osteomyelitis after infection with this elusive bug.

Case Description {#sec1-2}
================

A 74-year-old male patient with past medical history of essential hypertension, benign prostatic hyperplasia, asthma, and coronary artery disease presented with sternal chest pain. Upon examination, he was found to have wound dehiscence and sternal abscess. Patient had undergone a coronary artery bypass grafting (CABG) procedure 3 months back for his CAD. He underwent sternal debridement and removal of one sternal wire 1 month after the CABG. He endorsed minimal drainage from the sternal wound site. No associated fever, chills, nausea, vomiting, or shortness of breath were noted. Computed tomography (CT) scan of the chest showed persistent gas at the median sternotomy site with osseous destruction likely secondary to chronic osteomyelitis with abscess \[[Figure 1](#F1){ref-type="fig"}\]. Post debridement, specimen was initially identified as a *Corynebacterium*; the patient received broad coverage with IV vancomycin and meropenem. The sternal abscess was drained by surgery and deep tissue cultures were sent for special microbiological testing.

![Computed tomography of the chest shows osteomyelitis of the sternum (red arrow)](ACA-22-221-g001){#F1}

Discussion {#sec1-4}
==========

We isolated *G. bronchialis* from sternal deep tissue wound cultures of a patient who had undergone CABG 3 months back. *G. bronchialis* was the only microorganism cultured from the patient, and the patient was the only one with *G. bronchialis* infection in the hospital at the time. More than one specimen grew the same organism. Therefore, we can safely conclude that it was a true pathogen.

*Gordonia* (previously known as Gordona) genus was first isolated from other aerobic actinomycetes in 1971.\[[@ref8]\] Because awareness about *Gordonia* is slowly increasing, it now comprises a significant minority of aerobic actinomycetes found in humans. One study reported that of 171 aerobic actinomycete isolates sent to the National Institutes of Health from 1996 to 2003, approximately 56% were *Nocardia* spp., 12% *Mycobacteria* spp., 11% *Streptomyces* spp., 8% *Rhodococcus* spp., 6% *Gordonia* spp., 0.6% Tsukamurella spp., and 0.6% *Corynebacterium* spp.\[[@ref9]\]

Since 1971, 29 different *Gordonia* species have been isolated. Though the literature is scarce, there are few published reports of ventriculitis with an underlying ventricular shunt,\[[@ref10]\] otitis externa and bronchitis,\[[@ref11]\] arthritis associated with a biological absorbable bone/joint screw,\[[@ref12]\] breast abscess,\[[@ref13][@ref14]\] keratitis/conjunctivitis,\[[@ref15]\] skin and soft tissue infections,\[[@ref16][@ref17]\] and endocarditis from underlying central venous catheter.\[[@ref18][@ref19]\] A Spanish hospital published a report on Gordonia induced skin abscess, due to needle injection.\[[@ref20]\] Two cases of peritoneal dialysis-related peritonitis by Gordonia have also been reported.\[[@ref21][@ref22]\]

In our review of the literature, we found only 6 reported cases of *G. bronchialis* sternal infection in humans over the past 26 years \[[Table 1](#T1){ref-type="table"}\]. Most of the reported sternal wound infections were due to outbreak in the hospital due to intraoperative transmission from a health care worker. A cluster of 7 cases after coronary artery bypass surgery were traced back to the dog of an operating room nurse. Ciprofloxacin, ceftriaxone, and cotrimoxazole were used as therapy.\[[@ref3]\] One patient developed wound dehiscence post sternal closure following mitral valve replacement surgery. Samples from the wound site grew *G bronchialis*; clindamycin and ceftazidime were given.\[[@ref23]\] A cluster of three cases developed sternal osteomyelitis following CABG; they were treated by wound debridement and negative pressure.\[[@ref24]\] Another case after CABG was treated with vancomycin and cefotetan.\[[@ref25]\] Similarly ceftriaxone and ciprofloxacin were used in 2013 following CABG.\[[@ref26]\]

###### 

Reported cases of sternal infection by *Gordonia*

  Number of cases   Age     Sex           Year   Procedure                  Immunity status                                                                                                                 Therapy                                                                Treatment duration                                  Method of identification        Reference
  ----------------- ------- ------------- ------ -------------------------- ------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- --------------------------------------------------- ------------------------------- -----------
  1                 64      Female        2016   Mitral valve replacement   Normal                                                                                                                          Clindamycin and ceftazidime                                            8 weeks                                             16 sRNA sequencing              [@ref28]
  3                 47-68   Male/Female   2014   CABG                       Normal                                                                                                                          Wound debridement and negative pressure wound therapy                  Unknown                                             NA                              [@ref25]
  1                 69      Female        2014   CABG                       Diabetes Mellitus                                                                                                               Vancomycin and Cefotetan; imipenem                                     8 weeks                                             16sRNA sequencing               [@ref26]
  1                 76      Female        2013   CABG                       Normal                                                                                                                          Ceftriaxone and ciprofloxacin; wound debridement and VAC               Unknown                                             16sRNA sequencing               [@ref27]
  3 (Cluster)       56-80   Male          2012   CABG                       Diabetes Mellitus (2 cases), Normal (1 case)                                                                                    Imipenem, moxifloxacin, linezolid and minocycline; wound debridement   60 days (mean), 120 days respectively               16sRNA sequencing               [@ref4]
  7 (cluster)       51-68   Male          1991   CABG                       Diabetes mellitus (1 case), Steroid use (1 case), Obesity (3 cases), Prostate cancer (1 case), chronic lung disease (2 cases)   Ciprofloxacin, Cotrimoxazole, Ceftriaxone and Ciprofloxacin            74 days, 122 days, 38 days 108 days respectively.   Conventional biochemical test   [@ref3]

Salient points of this report {#sec2-1}
-----------------------------

The importance of correctly identifying *Gordonia* infection cannot be stressed enough. The most common confounding pathogen in making the correct diagnosis, is the coryneform Gram-positive rod\[[@ref10]\]Currently 16S rDNA or hsp65 gene sequencing is used to identify *G. bronchialis* at the species level. Mass spectrometry using matrix-assisted laser desorption ionization-time of flight mass spectrometry allows rapid identification of aerobic actinomycetes from cultured colonies. However, the isolate yielded log score between \<2 and ≥1.7 cannot be used to be identify at the species levelNo conclusive evidence-based treatment guidelines exist for *G. bronchialis* infection. Minocycline and ciprofloxacin were used in one report.\[[@ref27]\] In another case, carbapenem or fluoroquinolone in combination with an aminoglycoside was used.\[[@ref27]\] Trimethoprim-sulfamethoxazole has been reported to have poor efficacy against *Gordonia* species\[[@ref28]\]With the advent of 16S rRNA gene sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), *Gordonia* isolation is becoming more common. In the past, *G. bronchialis* infection has been underdiagnosed due to laboratory and technical limitationsThis case report adds to the accumulating evidence for identifying and treating this rare Gram-positive bacterium and urges physicians to be mindful of its idiosyncrasy to cause sternal infections.
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